本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Viking Therapeutics, Inc.

28.62
-0.2550-0.88%
盘后28.740.1250+0.44%19:55 EDT
成交量:346.55万
成交额:9,873.17万
市值:32.14亿
市盈率:-24.81
高:29.01
开:28.91
低:27.69
收:28.87
数据加载中...
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

重要事件披露

Form 8-K - Current report
2024/03/26

重要事件披露

Form 8-K - Current report
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report